Novel method to characterize CYP21A2 in Florida patients with congenital adrenal hyperplasia and commercially available cell lines
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder and affects approximately 1 in 15,000 births in the United States. CAH is one of the disorders included on the Newborn Screening (NBS) Recommended Uniform Screening Panel. The commonly used immunological NBS test is associated with a high false positive rate and there is interest in developing second-tier assays to increase screening specificity. Approximately 90% of the classic forms of CAH, salt-wasting and simple virilizing, are due to mutations in the CYP21A2 gene. These include single nucleotide changes, insertions, deletions, as well as chimeric genes involving CYP21A2 and its highly homologous pseudogene CYP21A1P. A novel loci-specific PCR approach was developed to individually amplify the CYP21A2 gene, the nearby CYP21A1P pseudogene, as well as any 30 kb deletion and gene conversion mutations, if present, as single separate amplicons. Using commercially available CAH positive specimens and 14 families with an affected CAH proband, the single long-range amplicon approach demonstrated higher specificity as compared to previously published methods.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468 · cited 1×
“An alternative second-tier test to enhance the specificity of CAH screening is molecular analysis of the CYP21A2 gene [17–19].”
BackgroundCongenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Carrier testing for severe childhood recessive diseases by next-generation sequencing
Bell, C. J., Dinwiddie, D. L., Miller, N. A., Hateley, S. L., Ganusova, E. E., Mudge, J., Langley, R. J., Zhang, L., Lee, C. C., Schilkey, F. D., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001756 · Cited by 706 · cited 1×
“Other methods based on hybrid capture enrichment of sheared DNA for next generation DNA sequencing have been described [25].”
MethodHigashi, Y., Yoshioka, H., Yamane, M., Gotoh, O., & Fujii-Kuriyama, Y. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2841 · Cited by 555 · cited 1×
“The CYP21A2 gene and the corresponding pseudogene each consist of 10 exons and are highly homologous, sharing approximately 98% nucleotide sequence identity [5].”
BackgroundKrone, N., Braun, A., Roscher, A. A., Knorr, D., & Schwarz, H. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6441 · Cited by 397 · cited 1×
“There are documented cases of CAH patients with only one detected CYP21A2 allele and that the expression of disease may be related to a combination of unresolved multiple genetic and/or environmental factors [34–36].”
BackgroundNew, M. I., Abraham, M., Gonzalez, B., Dumic, M., Razzaghy-Azar, M., Chitayat, D., Sun, L., Zaidi, M., Wilson, R. C., & Yuen, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300057110 · Cited by 365
Genetics of congenital adrenal hyperplasia
Krone, N., & Arlt, W. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.014 · Cited by 312
Neonatal screening for congenital adrenal hyperplasia
White, P. C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.148 · Cited by 240
Matern, D., Tortorelli, S., Oglesbee, D., Gavrilov, D., & Rinaldo, P. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0691-y · Cited by 217
Janzen, N., Peter, M., Sander, S., Steuerwald, U., Terhardt, M., Holtkamp, U., & Sander, J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2890 · Cited by 211
Finkielstain, G. P., Chen, W., Mehta, S. P., Fujimura, F. K., Hanna, R. M., Van Ryzin, C., McDonnell, N. B., & Merke, D. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0319 · Cited by 192 · cited 2×
“The remaining alleles identified were part of the 12 most common CYP21A2 mutations previously identified [9,32] : IVS2-13 A/C- N G (c.”
BackgroundMinutti, C. Z., Lacey, J. M., Magera, M. J., Hahn, S. H., McCann, M., Schulze, A., Cheillan, D., Dorche, C., Chace, D. H., Lymp, J. F., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032235 · Cited by 154
Schwarz, E., Liu, A., Randall, H., Haslip, C., Keune, F., Murray, M., Longo, N., & Pasquali, M. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181aa3777 · Cited by 97 · cited 1×
“The first is the use of second-tier liquid chromatography tandem mass spectrophotometry (LC-MS/MS) methods to compare steroid profile measurements in the DBS specimen to increase testing accuracy [10–13].”
MethodParajes, S., Quinteiro, C., Domínguez, F., & Loidi, L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002138 · Cited by 87
Junction Site Analysis of Chimeric CYP21A1P/CYP21A2 Genes in 21-Hydroxylase Deficiency
Chen, W., Xu, Z., Sullivan, A., Finkielstain, G. P., Van Ryzin, C., Merke, D. P., & McDonnell, N. B. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.174037 · Cited by 86
Araújo, R. S., Mendonca, B. B., Barbosa, A. S., Lin, C. J., Marcondes, J. A. M., Billerbeck, A. E. C., & Bachega, T. A. S. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2163 · Cited by 70
Comparison of one-tier and two-tier newborn screening metrics for congenital adrenal hyperplasia
Sarafoglou, K., Banks, K., Gaviglio, A., Hietala, A., McCann, M., & Thomas, W. (2012) · PEDIATRICS · doi:10.1542/peds.2012-1219 · Cited by 69
Cases of congenital adrenal hyperplasia missed by newborn screening in Minnesota
Sarafoglou, K., Banks, K., Kyllo, J., Pittock, S., & Thomas, W. (2012) · JAMA · doi:10.1001/jama.2012.5281 · Cited by 62 · cited 1×
“This result may be due to the use of the same DBS specimen utilized for the primary immune-assay and not a repeat DBS sample which would have increasing levels of 17-OHP for a true positive that accumulate with age in CAH [14,15].”
ResultKösel, S., Burggraf, S., Fingerhut, R., Dörr, H. G., Roscher, A. A., & Olgemöller, B. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.042416 · Cited by 52 · cited 1×
“A retrospective genotyping study of 61 CAH diagnosed samples from 810,000 newborns screened between January 1999 and December 2003 in Germany identified 59 patients with CYP21A2 mutations, one patient with 3β-hydroxysteroid deficiency and one patient with no CYP21A2 mutations [18].”
Standard enrichment methods for targeted next-generation sequencing in high-repeat genomic regions
Mueller, P. W., Lyons, J., Kerr, G., Haase, C. P., & Isett, R. B. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.119 · Cited by 11
Self-citation
Cited by
Baumgartner-Parzer, S., Witsch-Baumgartner, M., & Hoeppner, W. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0653-5 · Cited by 110
Comprehensive analysis of congenital adrenal hyperplasia using long-read sequencing
Liu, Y., Chen, M., Liu, J., Mao, A., Teng, Y., Yan, H., Zhu, H., Li, Z., Liang, D., & Wu, L. (2022) · Clinical Chemistry · doi:10.1093/clinchem/hvac046 · Cited by 80
Targeted gene panel sequencing for molecular diagnosis of congenital adrenal hyperplasia
Wang, W., Han, R., Yang, Z., Zheng, S., Li, H., Wan, Z., Qi, Y., Sun, S., Ye, L., & Ning, G. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105899 · Cited by 27
Sarafoglou, K., Gaviglio, A., Wolf, C., Lorentz, C. P., Lteif, A., Kyllo, J., Radloff, G., Detwiler, Z., Cuthbert, C. D., Hodges, J. S., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae297 · Cited by 8
“The Centers for Disease Control and Prevention (CDC) Newborn Screening and Molecular Biology Branch processed the blood samples to extract DNA, cryopreserve white blood cells, and create DBS.”
InfluentialSelf-citationZeng, J., Huang, X., Li, Y., Yan, T., Lou, J., Lyu, G., & Li, Y. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1603819 · Cited by 2
Metadata
- Authors
- Greene, C. N., Cordovado, S. K., Turner, D. P., Keong, L. M., Shulman, D., & Mueller, P. W.
- Venue
- Molecular Genetics and Metabolism Reports
- Publisher
- Elsevier BV
- Published
- 2014
- Volume
- 1
- Pages
- 312-323
- ISSN
- 2214-4269 (ISSN-L)
- OpenAlex
- W2075232290
- Cited by
- 19
- References
- 20
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.